Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs. [electronic resource]
Producer: 20070815Description: 34-41 p. digitalISSN:- 0971-9784
- Analysis of Variance
- Animals
- Biomarkers -- blood
- Blood Pressure -- drug effects
- Calcium Channel Blockers -- pharmacology
- Cardiac Output -- drug effects
- Cardiotonic Agents -- pharmacology
- Coronary Stenosis -- complications
- Diltiazem -- pharmacology
- Disease Models, Animal
- Heart Rate -- drug effects
- Lactic Acid -- blood
- Milrinone -- pharmacology
- Myocardial Contraction -- drug effects
- Myocardial Reperfusion
- Myocardial Stunning -- drug therapy
- Phosphodiesterase Inhibitors -- pharmacology
- Research Design
- Swine
- Time Factors
- Vascular Resistance -- drug effects
- Ventricular Function, Left -- drug effects
- Ventricular Pressure -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.